High level expression of OSBPL11 is associated with atherosclerosis and Alzheimer's disease

With the global aging population, the incidence of aging-related diseases such as Alzheimer's disease (AD) and atherosclerosis (AS) is increasing. AS has also been identified as a key risk factor for AD. However, the conjoint molecular mechanisms driving these diseases remain unclear. This study first used bioinformatics analysis to analyze gene expression data in the cortex of AD patients and plaques of AS patients. We identified OSBPL11 as a gene whose expression co-increased under both conditions, and it is expressed in macrophages in AS patients and astrocytes in AD patients. Further validation was conducted through patient sample collection and an ApoE<sup>-/-</sup> mouse model. Strikingly, our findings suggest that OSBPL11 plays a role in the development of both AS and AD, and that there is increased co-localization of OSBPL11 with macrophages and astrocytes. This discovery offers new insights into the association between AS and AD and offers a new target for the treatment AS and AD.

Authors

Institutions

Publication Details

Journal
Inflammation
Published
2025-05-23
DOI
https://doi.org/10.1007/s10753-025-02252-1
Primary Topic
Atherosclerosis and Cardiovascular Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

High level expression of OSBPL11 is associated with atherosclerosis and Alzheimer's disease

Lushan Liu, Zhong Ren, Xi‐Yu Wu, Huayu Zhang et al.
Inflammation
Atherosclerosis and Cardiovascular Diseases
article

High level expression of OSBPL11 is associated with atherosclerosis and Alzheimer's disease

Lushan Liu, Zhong Ren, Xi‐Yu Wu, Huayu Zhang, Qian Xu, Qiong Xiang, Guixue Wang, Yanyu Chen, Naiqi He, Zhi-Han Tang
article en

Abstract

With the global aging population, the incidence of aging-related diseases such as Alzheimer's disease (AD) and atherosclerosis (AS) is increasing. AS has also been identified as a key risk factor for AD. However, the conjoint molecular mechanisms driving these diseases remain unclear. This study first used bioinformatics analysis to analyze gene expression data in the cortex of AD patients and plaques of AS patients. We identified OSBPL11 as a gene whose expression co-increased under both conditions, and it is expressed in macrophages in AS patients and astrocytes in AD patients. Further validation was conducted through patient sample collection and an ApoE<sup>-/-</sup> mouse model. Strikingly, our findings suggest that OSBPL11 plays a role in the development of both AS and AD, and that there is increased co-localization of OSBPL11 with macrophages and astrocytes. This discovery offers new insights into the association between AS and AD and offers a new target for the treatment AS and AD.

InflammationVol. 48(5)
Ministry of Education (TH), University of South China (CN)
Natural Science Foundation of Hunan Province, University of South China
Good health and well-being
Openalex Percentile: Top 87%
Atherosclerosis and Cardiovascular Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.